by EmpathiCSubstanceS | Nov 4, 2020 | MDMA Sassafras Molly
The nation’s leading psychedelics research organization announced on Thursday that it has raised $30 million in donations—including from several notable business leaders outside the drug policy realm—that will enable it to complete a study on using MDMA to treat...
by EmpathiCSubstanceS | Nov 2, 2020 | Ayahuasca, Cancer, DMT, Kambo, LSD, MDMA Sassafras Molly
~5000 BCE Frescos of mushroom-holding shamans were depicted in caves on the Tassili plateau of Southeastern Algeria. See from original source HERE Psychedelic Timeline
by EmpathiCSubstanceS | Oct 30, 2020 | Depression, Microdosing
Formerly known only to the underground psychedelic community, the practice of taking microdoses of psychedelic drugs for a variety of purported benefits has made its way to the wider mainstream society. Just for starters, microdosers have reported experiencing...
by EmpathiCSubstanceS | Jul 13, 2020 | Pain
Using psychedelics to treat chronic pain is understudied yet full of potential. In a May 2020 paper published in the journal Regional Anesthesia and Pain Medicine, researchers from the University of California San Diego reviewed the psychedelic literature and proposed...
by EmpathiCSubstanceS | Jul 13, 2020 | MDMA Sassafras Molly, PTSD
Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced the results of an interim analysis of the data from the first of its two Phase 3 clinical trials of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD). This...
